CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers

PURPOSE: To determine the optimal chemotherapy backbone for testing in future US cooperative group studies for metastatic esophageal and gastroesophageal junction cancers. Cetuximab was added to each treatment arm based on promising preclinical data. PATIENTS AND METHODS: Patients with previously un...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Enzinger, Peter C., Burtness, Barbara Ann, Niedzwiecki, Donna, Ye, Xing, Douglas, Kathe, Ilson, David H., Villaflor, Victoria Meucci, Cohen, Steven J., Mayer, Robert J., Venook, Alan, Benson, Al Bowen, Goldberg, Richard M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2016
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5019745/
https://ncbi.nlm.nih.gov/pubmed/27382098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.65.5092
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados